Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) saw an uptick in trading volume on Thursday . Oxford BioMedica Stock PerformanceThe company has a quick ratio of 1.67, a current ratio of 1.89 and a debt-to-equity ratio of 3.08. Get Oxford BioMedica alerts:Oxford BioMedica Company Profile(Get Free Report)Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications. Read MoreReceive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.